Holdings
GSK plc
As of Sep 30, 2026, GSK plc reported 11 positions worth US$285M. Largest: Vir Biotechnology, Inc., BioNTech SE and IDEAYA Biosciences, Inc. What it bought and sold, with each filing.
| Company | Shares | Value as reported | Change | As of |
|---|---|---|---|---|
| Vir Biotechnology, Inc. | 8.55M | US$95.6M | no change | Sep 30, 2026 |
| BioNTech SE | 669K | US$65.7M | new | Sep 30, 2026 |
| IDEAYA Biosciences, Inc. | 1.33M | US$51.2M | no change | Sep 30, 2026 |
| Cytokinetics, Incorporated | 340K | US$22.4M | no change | Sep 30, 2026 |
| Lyell Immunopharma, Inc. | 1.51M | US$14.8M | no change | Sep 30, 2026 |
| Spero Therapeutics, Inc. | 9.19M | US$11.1M | no change | Sep 30, 2026 |
| Nkarta, Inc. | 3.15M | US$8.25M | no change | Sep 30, 2026 |
| Fulcrum Therapeutics, Inc. | 1.79M | US$6.61M | no change | Sep 30, 2026 |
| Bicycle Therapeutics PLC | 1.53M | US$5.63M | new | Sep 30, 2026 |
| Regenxbio Inc. | 271K | US$2.04M | no change | Sep 30, 2026 |